MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$81K
Net Income
-$26,786K
Net Profit Margin
-33069.14%
EPS
-$0.22
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
Grant revenue
81
43
209
Research and development
21,544
32,924
20,339
General and administrative
7,795
6,951
7,731
Goodwill impairment
-
0*
-
Loss on disposal of property and equipment
-
0*
-
Total operating expenses
29,339
39,875
28,070
Operating loss
-29,258
-39,832
-27,861
Interest income
2,347
1,614
1,957
Interest and other expense
71
64
65
Other income from a related party (note 3)
0
0
0
Equity in loss of affiliate
-1
-1
0
Total non-operating income, net
2,275
1,549
1,892
Net loss from continuing operations
-26,983
-38,283
-25,969
Net loss from discontinued operations
197
595
0
Net loss before deferred income tax benefit
-26,786
-37,688*
-
Deferred income tax benefit
0
-198*
-
Net loss
-26,786
-37,490
-25,969
Basic EPS
-0.22
-0.504
-0.35
Diluted EPS
-0.22
-0.504
-0.35
Basic Average Shares
120,651,000
74,364,000
74,296,000
Diluted Average Shares
120,651,000
74,364,000
74,296,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$26,786K
(-24.67%↓ Y/Y)
Net loss before
deferred income tax...
-$26,786K
Net loss from
discontinued operations
$197K
(-61.67%↓ Y/Y)
Interest income
$2,347K
(8.71%↑ Y/Y)
Net loss from
continuing operations
-$26,983K
(-22.66%↓ Y/Y)
Total non-operating
income, net
$2,275K
(11.52%↑ Y/Y)
Interest and other
expense
$71K
(-40.34%↓ Y/Y)
Equity in loss of
affiliate
-$1K
Operating loss
-$29,258K
(-21.71%↓ Y/Y)
Grant revenue
$81K
(-72.07%↓ Y/Y)
Total operating
expenses
$29,339K
(20.59%↑ Y/Y)
Research and development
$21,544K
(29.63%↑ Y/Y)
General and
administrative
$7,795K
(1.12%↑ Y/Y)
Buy us a coffee
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)